Contributions of the Regional Emerging Special Pathogen Treatment Centers to the US COVID-19 Pandemic Response

Elemento

Click for External Resource*

https://pubmed.ncbi.nlm.nih.gov/35483049/

Click to read full article*

https://www.liebertpub.com/doi/10.1089/hs.2021.0188

The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.

Item Type

Publicación

Terms of Use

By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.

Share this page:

Facebook Twitter e-mail

Was this resource helpful?

Título

Contributions of the Regional Emerging Special Pathogen Treatment Centers to the US COVID-19 Pandemic Response

Materia

Emergency Management

Descripción

Autor

Jonathan D Grein, Jennifer A Garland, Christa Arguinchona, Maria G Frank, Brian T Garibaldi, Amanda Grindle, Angela Hewlett, Susan Kline, Corri B Levine, Aneesh Mehta, Vikramjit Mukherjee, Lauren M Sauer, Eileen F Searle, Sharon Vanairsdale, Angela Vasa

Fecha

2022-05-31

Tipo

Publication

Citación

Grein, J. D., J. A. Garland, C. Arguinchona, M. G. Frank, B. T. Garibaldi, A. Grindle, A. Hewlett, S. Kline, C. B. Levine, A. Mehta, V. Mukherjee, L. M. Sauer, E. F. Searle, S. Vanairsdale, and A. Vasa. 2022. "Contributions of the Regional Emerging Special Pathogen Treatment Centers to the US COVID-19 Pandemic Response." Health Secur 20 (S1):S4-s12. doi: 10.1089/hs.2021.0188.

Resumen

The National Emerging Special Pathogens Training and Education Center (NETEC) was established in 2015 to improve the capabilities of healthcare facilities to provide safe and effective care to patients with Ebola and other special pathogens in the United States. Through NETEC, a collaborative network of 10 Regional Emerging Special Pathogen Treatment Centers (RESPTCs) undertook readiness activities that included potential respiratory pathogens. These preparations, which took place before the COVID-19 pandemic, established a foundation of readiness that enabled RESPTCs to play a pivotal role in the US COVID-19 pandemic response. As initial COVID-19 cases were detected in the United States, RESPTCs provided essential isolation capacity, supplies, and subject matter expertise that allowed for additional time for healthcare systems to prepare. Through the Special Pathogen Research Network, RESPTCs rapidly enrolled patients into early clinical trials. During periods of high community transmission, RESPTCs provided educational, clinical, and logistical support to a wide range of healthcare and nonhealthcare settings. In this article, we describe how NETEC and the RESPTC network leveraged this foundation of special pathogen readiness to strengthen the national healthcare system's response to the COVID-19 pandemic. NETEC and the RESPTC network have proven to be an effective model that can support the national response to future emerging special pathogens.